Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 491 to 500 of 1898

TitleReference numberPublishedLast updated
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resectionTA761
Rehabilitation after traumatic injuryNG211
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA760
Cabotegravir with rilpivirine for treating HIV-1TA757
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Headaches in over 12s: diagnosis and managementCG150
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Cenobamate for treating focal onset seizures in epilepsyTA753

Results per page

  1. 10
  2. 25
  3. 50
  4. All